Meeting
2018 Gastrointestinal Cancers Symposium
Lenvatinib plus checkpoint inhibitors in patients (pts) with advanced intrahepatic cholangiocarcinoma (ICC): Preliminary data and correlation with next-generation sequencing.
Authors
Jianzhen Lin
Peking Union Medical College Hospital/ Chinese Academy of Medical Sciences, Beijing, China
Jianzhen Lin , Weiwei Shi , Songhui Zhao , Jinwei Hu , Zheng Hou , Ming Yao , Gungwei Chrin , Jie Pan , Ke Hu , Lin Zhao , Milind Javle , Kai Wang , Haitao Zhao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 500)
DOI
10.1200/JCO.2018.36.4_suppl.500
Abstract #
500
Poster Bd #
N24
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2019 ASCO Annual Meeting
Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable alterations in advanced cholangiocarcinoma.
First Author: Ian M. Silverman
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical and mutational profiles of microsatellite instability (MSI-H) in intrahepatic cholangiocarcinoma (iCCA).
First Author: Madhulika Eluri